Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Bioequivalence Study for Benzyl Alcohol Lotion 5%.

ClinicalTrials.gov ID: NCT02624843

Public ClinicalTrials.gov record NCT02624843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Bioequivalence Study for Benzyl Alcohol Lotion 5% (Hi-Tech Pharmacal Co. LTD) and Ulesfia (Benzyl Alcohol Lotion 5%) (Shionogi Inc.) in the Treatment of Head Lice and Their Ova.

Study identification

NCT ID
NCT02624843
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Akorn, Inc.
Industry
Enrollment
239 participants

Conditions and interventions

Conditions

Interventions

  • Benzyl Alcohol Lotion 5% Drug
  • Ulesfia (benzyl alcohol lotion) 5% Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
6 Months to 60 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2015
Primary completion
Oct 31, 2015
Completion
Oct 31, 2015
Last update posted
Jan 26, 2021

2015

United States locations

U.S. sites
4
U.S. states
2
U.S. cities
3
Facility City State ZIP Site status
Axis Clinical Trials Los Angeles California 90017
Axis Clinical Trials Los Angeles California 90036
South Florida Family Health and Research Centers (Lice Source Services Inc) Miami Florida 33186
South Florida Family Health and Research Centers (Lice Source Services Inc) Plantation Florida 33313

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02624843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2021 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02624843 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →